O'Brien SM - Search Results

1

Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib.

Jones JA, Hillmen P, Coutre S, Tam C, Furman RR, Barr PM, Schuster SJ, Kipps TJ, Flinn IW, Jaeger U, Burger JA, Cheng M, Ninomoto J, James DF, Byrd JC, O'Brien SM. Jones JA, et al. Br J Haematol. 2017 Jul;178(2):286-291. doi: 10.1111/bjh.14660. Epub 2017 Apr 10. Br J Haematol. 2017. PMID: 28397242 Free PMC article. Clinical Trial.

2

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.

Keating MJ, Kantarjian H, O'Brien S, Koller C, Talpaz M, Schachner J, Childs CC, Freireich EJ, McCredie KB. Keating MJ, et al. J Clin Oncol. 1991 Jan;9(1):44-9. doi: 10.1200/JCO.1991.9.1.44. J Clin Oncol. 1991. PMID: 1702145 Clinical Trial.

3

Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patients.

Kurzrock R, Talpaz M, Gomez JA, Estey EH, O'Brien S, Hirsch-Ginsberg C, Koller C, Freireich EJ, Gutterman JU. Kurzrock R, et al. Br J Haematol. 1991 Jul;78(3):352-8. doi: 10.1111/j.1365-2141.1991.tb04448.x. Br J Haematol. 1991. PMID: 1873220

4

Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes.

Estey EH, Kurzrock R, Talpaz M, McCredie KB, O'Brien S, Kantarjian HM, Keating MJ, Deisseroth AB, Gutterman JU. Estey EH, et al. Br J Haematol. 1991 Mar;77(3):291-5. doi: 10.1111/j.1365-2141.1991.tb08573.x. Br J Haematol. 1991. PMID: 2012752

5

Clinical experience with fludarabine in leukaemia.

Keating MJ, Estey E, O'Brien S, Kantarjian H, Robertson LE, Plunkett W. Keating MJ, et al. Drugs. 1994;47 Suppl 6:39-49. doi: 10.2165/00003495-199400476-00007. Drugs. 1994. PMID: 7525188 Review.

6

Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia.

Robertson LE, O'Brien S, Kantarjian H, Koller C, Beran M, Andreeff M, Lerner S, Keating MJ. Robertson LE, et al. Leukemia. 1995 Jun;9(6):943-5. Leukemia. 1995. PMID: 7596181 Clinical Trial.

7

Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy.

O'Brien S, Kantarjian H, Beran M, Robertson LE, Koller C, Lerner S, Keating MJ. O'Brien S, et al. Blood. 1995 Aug 15;86(4):1298-300. Blood. 1995. PMID: 7632936 Clinical Trial.

8

A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemia.

Robertson LE, O'Brien S, Kantarjian H, Koller C, Beran M, Andreeff M, Lerner S, Plunkett W, Keating MJ. Robertson LE, et al. Leukemia. 1995 Sep;9(9):1444-9. Leukemia. 1995. PMID: 7658710

9

Acute lymphocytic leukaemia in the elderly: characteristics and outcome with the vincristine-adriamycin-dexamethasone (VAD) regimen.

Kantarjian HM, O'Brien S, Smith T, Estey EH, Beran M, Preti A, Pierce S, Keating MJ. Kantarjian HM, et al. Br J Haematol. 1994 Sep;88(1):94-100. doi: 10.1111/j.1365-2141.1994.tb04982.x. Br J Haematol. 1994. PMID: 7803263

10

Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.

Robertson LE, Estey E, Kantarjian H, Koller C, O'Brien S, Brown B, Keating MJ. Robertson LE, et al. Leukemia. 1994 Dec;8(12):2047-51. Leukemia. 1994. PMID: 7807993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

532 results

Search Page

Filters